350 related articles for article (PubMed ID: 14623404)
1. Collagen sponges for bone regeneration with rhBMP-2.
Geiger M; Li RH; Friess W
Adv Drug Deliv Rev; 2003 Nov; 55(12):1613-29. PubMed ID: 14623404
[TBL] [Abstract][Full Text] [Related]
2. Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2.
Itoh H; Ebara S; Kamimura M; Tateiwa Y; Kinoshita T; Yuzawa Y; Takaoka K
Spine (Phila Pa 1976); 1999 Jul; 24(14):1402-5. PubMed ID: 10423783
[TBL] [Abstract][Full Text] [Related]
3. Characterization of absorbable collagen sponges as rhBMP-2 carriers.
Friess W; Uludag H; Foskett S; Biron R; Sargeant C
Int J Pharm; 1999 Sep; 187(1):91-9. PubMed ID: 10502616
[TBL] [Abstract][Full Text] [Related]
4. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate.
Suh DY; Boden SD; Louis-Ugbo J; Mayr M; Murakami H; Kim HS; Minamide A; Hutton WC
Spine (Phila Pa 1976); 2002 Feb; 27(4):353-60. PubMed ID: 11840099
[TBL] [Abstract][Full Text] [Related]
5. The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model.
Hecht BP; Fischgrund JS; Herkowitz HN; Penman L; Toth JM; Shirkhoda A
Spine (Phila Pa 1976); 1999 Apr; 24(7):629-36. PubMed ID: 10209790
[TBL] [Abstract][Full Text] [Related]
6. Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers.
Kim CS; Kim JI; Kim J; Choi SH; Chai JK; Kim CK; Cho KS
Biomaterials; 2005 May; 26(15):2501-7. PubMed ID: 15585252
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial.
Dawson E; Bae HW; Burkus JK; Stambough JL; Glassman SD
J Bone Joint Surg Am; 2009 Jul; 91(7):1604-13. PubMed ID: 19571082
[TBL] [Abstract][Full Text] [Related]
8. Retention of 125I-labeled recombinant human bone morphogenetic protein-2 by biphasic calcium phosphate or a composite sponge in a rabbit posterolateral spine arthrodesis model.
Louis-Ugbo J; Kim HS; Boden SD; Mayr MT; Li RC; Seeherman H; D'Augusta D; Blake C; Jiao A; Peckham S
J Orthop Res; 2002 Sep; 20(5):1050-9. PubMed ID: 12382973
[TBL] [Abstract][Full Text] [Related]
9. Effect of surgical implantation of recombinant human bone morphogenetic protein-2 in a bioabsorbable collagen sponge or calcium phosphate putty carrier in intrabony periodontal defects in the baboon.
Blumenthal NM; Koh-Kunst G; Alves ME; Miranda D; Sorensen RG; Wozney JM; Wikesjö UM
J Periodontol; 2002 Dec; 73(12):1494-506. PubMed ID: 12546100
[TBL] [Abstract][Full Text] [Related]
10. Space-providing expanded polytetrafluoroethylene devices define alveolar augmentation at dental implants induced by recombinant human bone morphogenetic protein 2 in an absorbable collagen sponge carrier.
Wikesjö UM; Qahash M; Thomson RC; Cook AD; Rohrer MD; Wozney JM; Hardwick WR
Clin Implant Dent Relat Res; 2003; 5(2):112-23. PubMed ID: 14536046
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronan supports recombinant human bone morphogenetic protein-2 induced bone reconstruction of advanced alveolar ridge defects in dogs. A pilot study.
Hunt DR; Jovanovic SA; Wikesjö UM; Wozney JM; Bernard GW
J Periodontol; 2001 May; 72(5):651-8. PubMed ID: 11394401
[TBL] [Abstract][Full Text] [Related]
12. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
Haid RW; Branch CL; Alexander JT; Burkus JK
Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
[TBL] [Abstract][Full Text] [Related]
13. A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats.
Miyazaki M; Morishita Y; He W; Hu M; Sintuu C; Hymanson HJ; Falakassa J; Tsumura H; Wang JC
Spine J; 2009; 9(1):22-30. PubMed ID: 18805060
[TBL] [Abstract][Full Text] [Related]
14. Delivery systems for BMPs: factors contributing to protein retention at an application site.
Uludag H; Gao T; Porter TJ; Friess W; Wozney JM
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S128-35. PubMed ID: 11314790
[TBL] [Abstract][Full Text] [Related]
15. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates.
Barnes B; Boden SD; Louis-Ugbo J; Tomak PR; Park JS; Park MS; Minamide A
Spine (Phila Pa 1976); 2005 May; 30(10):1127-33. PubMed ID: 15897825
[TBL] [Abstract][Full Text] [Related]
16. Effect of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) on healing in 3-wall intrabony defects in dogs.
Choi SH; Kim CK; Cho KS; Huh JS; Sorensen RG; Wozney JM; Wikesjö UM
J Periodontol; 2002 Jan; 73(1):63-72. PubMed ID: 11852905
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Healos/bone marrow to INFUSE(rhBMP-2/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion.
Kraiwattanapong C; Boden SD; Louis-Ugbo J; Attallah E; Barnes B; Hutton WC
Spine (Phila Pa 1976); 2005 May; 30(9):1001-7; discussion 1007. PubMed ID: 15864149
[TBL] [Abstract][Full Text] [Related]
18. Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog.
Barboza EP; Duarte ME; Geolás L; Sorensen RG; Riedel GE; Wikesjö UM
J Periodontol; 2000 Mar; 71(3):488-96. PubMed ID: 10776939
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human bone morphogenetic protein-2: a novel osteoinductive alternative to autogenous bone graft?
Szpalski M; Gunzburg R
Acta Orthop Belg; 2005 Apr; 71(2):133-48. PubMed ID: 16152845
[TBL] [Abstract][Full Text] [Related]
20. Effect of recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge with space-providing biomaterials on the augmentation of chronic alveolar ridge defects.
Barboza EP; Caúla AL; Caúla Fde O; de Souza RO; Geolás Neto L; Sorensen RG; Li XJ; Wikesjö UM
J Periodontol; 2004 May; 75(5):702-8. PubMed ID: 15212353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]